Switch View
© PR Newswire
28.08.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 27 August 2025 was 356.14p (cum income). ...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US81749D1072
Sera Prognostics Inc
SERA
LISTED
NASDAQ
SERA PROGNOSTICS TO PRESENT AT H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE
News Preview
SALT LAKE CITY, Aug. 28, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the H.C. Wainwright 27th Annual Global Investment Conference...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Hit With Securities Class Action After Shares Crash 44% On Q2 2025 Earnings Surprise, Problems With Obesity Care and RexMD -- Hagens Berman
News Preview
SAN FRANCISCO, Aug. 28, 2025 /PRNewswire/ -- A securities fraud class action lawsuit styled Johnston v. LifeMD, Inc., et al., No. 1:25-cv-04761 (E.D.N.Y) has been filed and seeks to represent LifeMD (NASDAQ: LFMD) investors who purchased or otherwise acquired LifeMD securities between May 7, 2025 and August 5, 2025....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
28.08.2025
ISIN: US6556631025
Nordson Corp
NDSN
LISTED
NASDAQ
Nordson Corporation Board of Directors Increases Dividend 5 Percent, Marking 62 Consecutive Years of Annual Dividend Increases
News Preview
Nordson Corporation (Nasdaq: NDSN) today announced that its Board of Directors has approved a five percent increase in the Company’s quarterly cash dividend to $0.82 per common share from $0.78. The dividend is payable on September 25, 2025, to shareholders of record as of the close of business on September 11, 2025.
This increase represents Nor...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
28.08.2025
ISIN: US6373722023
National Research Corp
NRC
LISTED
NASDAQ
NRC Health Announces Shane Harrison as Chief Financial Officer
News Preview
National Research Corporation (NASDAQ: NRC), doing business as NRC Health, a publicly-traded leader in healthcare experience, is pleased to announce the appointment of Shane Harrison as its incoming Executive Vice President and Chief Financial Officer, effective on or about September 25, 2025.
Chief Financial Officer
Shane Harrison is a season...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Signatera™ Test Selected for NRG-Sponsored Phase III ARCHER Trial in Bladder Cancer
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the activation of the NRG Oncology trial, ARCHER (NRG-GU015), a randomized, phase III study in muscle-invasive bladder cancer (MIBC). The study is evaluating whether a shorter course of radiation can achieve outcomes comparable to the current stan...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US89680M1018
TriSalus Life Sciences, Inc.
TLSI
LISTED
NASDAQ
TriSalus Life Sciences to Participate in Upcoming September Investor Conferences
News Preview
TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announced that Mary Szela,...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare showcases integrated cardiology care pathway solutions and new AI-driven innovations at ESC 2025
News Preview
Today, leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare (Nasdaq: GEHC) introduced its latest suite of cardiology innovations designed to enhance clinical decision-making, improve workflow efficiency, and support earlier diagnosis and treatment of cardiovascular disease (CVD)—the world’s leading cause of death, re...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US6412881053
Neuropace Inc
NPCE
LISTED
NASDAQ
NeuroPace to Participate in Upcoming Healthcare Conferences
News Preview
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in two healthcare conferences in September.
NeuroPace management will host one-on-one meetings with investors at the Wells Fargo 2025 Healthcare Conference, on Wedne...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US46266C1053
IQVIA Holdings Inc
IQV
LISTED
NYSE
IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies
News Preview
RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass., Aug. 28, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, and Flagship Pioneering, the bioplatform innovation company, today announced a strategic collaboration to accelerate the development of breakt...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: KYG9845F2080
LakeShore Biopharma Co Ltd
LSBCF
LISTED
OTC
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee
News Preview
BEIJING, Aug. 28, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that its board...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: IL0011313900
Galmed Pharmaceuticals Ltd.
GLMD
LISTED
NASDAQ
Galmed Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
News Preview
TEL AVIV, Israel, Aug. 28, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications, reports financial results for the three and six months ended June 30, 2025 and recent developments.
Recent Business Updat...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
28.08.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's iQ Food Co. QSR Signs 10-Unit Area Development Agreement in Atlantic Canada
News Preview
Toronto, Ontario--(Newsfile Corp. - August 28, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging food brands is pleased to announce that it has signed as of August 27th, 2025, an area development agreement for the provinces of Nova Scotia, New Brunswick, P.E.I, Newfou...
Themefolio
Profiler
Peergroup
© Newsfile
28.08.2025
ISIN: CA75671E1097
Red Light Holland Corp.
TRIP
LISTED
CSE
Red Light Holland Reports First Quarter 2026 Results
News Preview
Toronto, Ontario--(Newsfile Corp. - August 28, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: JP3701000006
JCR Pharmaceuticals Co., Ltd.
45520
LISTED
XJPX
JCR Pharmaceuticals to Present at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) 2025
News Preview
JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, announced today that it will present data at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) 2025, held September 2-6, 2025, in Kyoto, Japan. The presentations will de...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab Announces Participation in Investor Conferences in September 2025
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in September 2025:
Cantor Global Healthcare Conference
Presentation: Thursday, September 4, 2025, 10:20 a.m. ET
Location: New York, NY
Morgan Stanley 23rd Annual Global Healthcar...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care
News Preview
Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants
Dr. Anand M. Murthi Appointed Chief Medical Advisor, Shoulder, Sports, Extremities, and Trauma (S.E.T.)
WARSAW, Ind., Aug. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today ann...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US2197981051
QuidelOrtho Corp
QDEL
LISTED
NASDAQ
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference
News Preview
SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team will participate in the Baird 2025 Globa...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US89532M1018
Trevi Therapeutics Inc
TRVI
LISTED
NASDAQ
Trevi Therapeutics to Participate in Upcoming September Conferences
News Preview
NEW HAVEN, Conn., Aug. 28, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refr...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO to Participate in Upcoming Investor Conferences
News Preview
ROCKVILLE, Md., Aug. 28, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences:
2025 Wells Fargo Healthcare Conference 1x1 Investor Meetings: Thursday, September 4 Location: Boston, MA
Morgan Stanley 23rd Annual Global Healthcare Conference Fireside Chat: Monday, September 8,...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
News Preview
BARCELONA, Spain, Aug. 28, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in biotechnology, Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process, building on the company's commitment...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
News Preview
PLEASANTON, Calif., Aug. 28, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in biotechnology, Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process, building on the company's commitmen...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US01438T1060
Aldeyra Therapeutics Inc
ALDX
LISTED
NASDAQ
Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Primary Large B-Cell Lymphomas of Immune-Privileged Sites, including Primary Vitreoretinal Lymphoma
News Preview
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the European Medicines Agency (EMA) has granted Orphan Designation for ADX-2191 (methotrexate intravitreal injection, USP) for the treatment of primary large B-Cell lymphomas of immune-privileged sites, including primary vitreoretinal lymphoma. There is currently no approved...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US42238H1086
HeartBeam, Inc.
BEAT
LISTED
NASDAQ
HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025
News Preview
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that CEO Robert Eno and CFO Timothy Cruickshank will attend the MDB Investor Summit 2025, HRX Live 2025, and the H.C. Wainwright 27th Annual Global Investment Conference in September 2025. D...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: JE00BYSS4X48
Novocure Ltd
NVCR
LISTED
NASDAQ
Novocure Announces Upcoming Investor Events
News Preview
Novocure (NASDAQ: NVCR) announced today that management will participate in three upcoming investor events.
2025 Wells Fargo Healthcare Conference, September 4, 2025: Ashley Cordova, Chief Executive Officer, will take part in a fireside chat at 9:30 a.m. ET, as well as one-on-one meetings with investors throughout the event.
H.C. Wainwright...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed to Participate in September Investor Conferences
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences:
Cantor Global Healthcare Conference 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US1920051067
Codexis Inc
CDXS
LISTED
NASDAQ
Codexis to Participate in Cantor Global Healthcare Conference
News Preview
REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global Healthcare Conference, being held September 3-5, 2025, in New York, New York....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: SGXZ17669631
CytoMed Therapeutics Limited
GDTC
LISTED
NASDAQ
Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition
News Preview
SINGAPORE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, includi...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US8789721086
Tectonic Therapeutic Inc
TECX
LISTED
NASDAQ
Tectonic Therapeutic to Participate in September Investor Conferences
News Preview
WATERTOWN, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participa...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US9216591084
Vanda Pharmaceuticals Inc
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera
News Preview
WASHINGTON, Aug. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849B, a selective peptide nucleic acid-based JAK2 inhibitor for the treatment of polycythemia vera (PV)....
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US7469641051
Q32 Bio Inc
QTTB
LISTED
NASDAQ
Q32 Bio to Participate in the 2025 Wells Fargo Healthcare Conference
News Preview
WALTHAM, Mass., Aug. 28, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced that management will participate in a fireside chat at 3:45 p.m. E.T. on Thursday, Septemb...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US13471N3008
Can-Fite BioPharma Ltd.
CANF
LISTED
XASE
Can-Fite Reports H1 2025 Financial Results and Clinical Update
News Preview
Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced financial results and clinical updates for H1, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: KYG9390W1015
VIVA Biotech Holdings
1873
LISTED
HKSE
Viva Biotech Announces Its 2025 Interim Results: CRO Revenue Returned to Positive Growth, New CDMO Commercialization Projects Showed Promising Growth
News Preview
Results Highlights for Interim Results ended 30 June 2025
Revenue reached RMB831.9 million
Gross profit amounted to RMB339.4 million
Gross profit margin was 40.8%, an increase of 6.3 percentage point
Net profit amounted to RMB148.6 million, increased by 3.1% YoY
Adjusted non-IFRS net profit reached RMB183.5 million, increased by 9.1% YoY
SHANGHAI...
Themefolio
Profiler
Peergroup
© BusinessWire
28.08.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck to Participate in the 2025 Wells Fargo Healthcare Conference
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Caroline Litchfield, executive vice president and chief financial officer, and Eliav Barr, senior vice president, head of global clinical development and chief medical officer, Merck Research Laboratories, are scheduled to participate in a fireside chat a...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US21900C3088
CorMedix Inc
CRMD
LISTED
NASDAQ
CorMedix to Participate in Upcoming Investor Conferences
News Preview
BERKELEY HEIGHTS, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be presenting and participating in investor meetings at upcoming i...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US92346J1088
Vericel Corp
VCEL
LISTED
NASDAQ
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
News Preview
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside chat at the Wells Fargo Healthcare Conference at 3:45 p.m. ET on Thursday, September 4, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US09073N2018
BioSig Technologies, Inc.
BSGM
LISTED
NASDAQ
Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th
News Preview
LOS ANGELES, CA & VANCOUVER, BC , Aug. 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), a gold tokenization infrastructure company building the foundation for on-chain gold markets, today announced that it will participate...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US03836J1025
Aprea Therapeutics Inc
APRE
LISTED
NASDAQ
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference
News Preview
DOYLESTOWN, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while minimizing damage to healthy cells, today announced that management will present at the H.C. Wai...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: IL0006290147
Teva Pharmaceutical Industries Ltd
TEVA
LISTED
TLV
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
News Preview
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
ISIN: US6707031075
Nuvalent Inc
NUVL
LISTED
NASDAQ
Nuvalent to Participate in the Cantor Global Healthcare Conference 2025
News Preview
CAMBRIDGE, Mass., Aug. 28, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participat...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics to Participate in Upcoming Investor Conferences in September
News Preview
NEEDHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, announced today that Paul Peter Tak, M.D., Ph.D., FMedSci, Candel’s President and Chief Executive...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US14888U1016
Catalyst Pharmaceuticals Inc
CPRX
LISTED
NASDAQ
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
News Preview
CORAL GABLES, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Richard J. Daly, Pr...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US57055L1070
Marker Therapeutics, Inc.
MRKR
LISTED
NASDAQ
Marker Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that its Chief Executive Officer, Dr. Juan Vera, will partici...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US5019761049
Kyverna Therapeutics, Inc.
KYTX
LISTED
NASDAQ
Kyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event
News Preview
KYV-101 has the potential to deliver durable, drug-free, disease-free remission in myasthenia gravis and set a new treatment standard for stiff person syndrome...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US83422E1055
Solid Biosciences Inc.
SLDB
LISTED
XNMS
Solid Biosciences to Participate at Upcoming Investor Conferences
News Preview
CHARLESTOWN, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US0144421072
Alector Inc
ALEC
LISTED
NASDAQ
Alector to Participate in Upcoming Healthcare Conferences
News Preview
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US70261F1030
Pasithea Therapeutics Corp.
KTTA
LISTED
NASDAQ
Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Pasithea Tx (Nasdaq: KTTA) to present PAS-004 clinical progress at H.C. Wainwright Global Investment Conference on Sept. 10, 2025 in NYC....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US88032L6056
Tenax Therapeutics, Inc.
TENX
LISTED
NASDAQ
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
News Preview
CHAPEL HILL, N.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that the Company will participate in a fireside chat at the Cantor Global Heal...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will present at the Morgan Stanley 23rd Annual Global Healthcare Con...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US8162121045
Selecta Biosciences, Inc.
SELB
LISTED
NASDAQ
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
News Preview
FREDERICK, Md., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor conferences in September:...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains
News Preview
Tilray Affirms Continued Commitment to German Healthcare and Expanding Patient and Pharmacy Access in Europe's Largest Medical Cannabis Market Tilray Affirms Continued Commitment to German Healthcare and Expanding Patient and Pharmacy Access in Europe's Largest Medical Cannabis Market...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: US69012T2069
Outlook Therapeutics, Inc.
OTLK
LISTED
NASDAQ
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
News Preview
ISELIN, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) to its biologics license...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
ISIN: DK0011048619
BioPorto A/S
BIOPOR
LISTED
CPH
ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics.
News Preview
August 28, 2025News Release...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.08.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer expands financial flexibility to implement growth strategy
News Preview
Gerresheimer expands financial flexibility to implement growth strategy
Loans of EUR 200 million to repay part of the bridge financing for the acquisition of Bormioli Pharma ahead of schedule
Expansion of flexibility in key contractual terms
Duesseldorf, August 28, 2025. Gerresheimer, an innovative system and solution provider and global partner ......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.08.2025
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer weitet finanzielle Flexibilität zur Umsetzung der Wachstumsstrategie aus
News Preview
Gerresheimer weitet finanzielle Flexibilität zur Umsetzung der Wachstumsstrategie aus
Darlehen über 200 Mio. EUR zur vorzeitigen Ablösung eines Teils der Brückenfinanzierung für die Akquisition von Bormioli Pharma
Ausweitung der Flexibilität bei wesentlichen Vertragsbedingungen
Düsseldorf, 28. August 2025. Gerresheimer, innovativer System- und Lö......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
28.08.2025
ISIN: US14757U2087
CASI Pharmaceuticals, Inc.
CASI
LISTED
NASDAQ
CASI Pharmaceuticals to Participate at Cantor Global Healthcare Conference 2025
News Preview
SAN FRANCISCO, CA / ACCESS Newswire / August 28, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ transplant rejection and autoimmune diseases, today announced that David Cory, CEO, will participate in a fireside chat at the Cantor Global H...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
28.08.2025
ISIN: US45408X3089
IGC Pharma, Inc
IGC
LISTED
XASE
IGC Pharma receives Notice of Allowance for Novel THC Microdose-Based Treatment for Stammering, Stuttering, and Tourette's Syndrome
News Preview
POTOMAC, MD / ACCESS Newswire / August 28, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application US 17/613,909. The patent application, IGC510, is for a proprietary method for treating individuals suffering from stammer...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
28.08.2025
ISIN: US87975F1049
Telomir Pharmaceuticals, Inc.
TELO
LISTED
NASDAQ
Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases
News Preview
In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" that drives cancer growth. MIAMI, FLORIDA / ACCESS Newswire / August 28, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a preclinical-stage biotechnology company developing therapies that target the root mechanism...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
28.08.2025
ISIN: CA90468F1027
Unidoc Health Corp.
UDOC
LISTED
CSE
UniDoc Health Corp. Provides Corporate Update
News Preview
VANCOUVER, BC / ACCESS Newswire / August 28, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or "the Company") pleased to provide shareholders with a general corporate update, including an update on its financial filings, corporate activities, and market positioning.Financial statement filing updateUniDoc a...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.08.2025
ISIN: CH1243598427
Sandoz Group AG
SDZ
LISTED
XWSX
Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options
News Preview
Sandoz Group AG
/ Key word(s): Product Launch
Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options 28.08.2025 / 07:00 CET/CEST
Media Release
With introduction of 10 mg, 15 mg and 20 mg strengths, Sandoz now provides most comprehensive range of rivaroxaban film-coated tablets......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
